Antibody-Drug Conjugates (ADCs) are highly toxic drugs which can, in small amounts, posing significant risks to human health. As such, their production and handling require specialized facilities to ensure the safety of operators and prevent cross-contamination. Without these tailored facilities, the manufacturing of ADCs can result in the release of hazardous substances into the environment. However, preventing such contamination often entails a considerable environmental footprint. Additionally, the production of HPAPIs, which are involved in ADCs, contributes to environmental impacts through high energy consumption and waste generation.
This presentation examines innovative, sustainable approaches to ADC production, focusing on eco-friendly practices. It highlights how the adoption of green chemistry, renewable resources, and energy-efficient processes can reduce environmental impact while improving production efficiency and quality. Through case studies and practical examples, the presentation showcases how these methods are being implemented in industrial settings.